Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Perficient Inc
(NQ:
PRFT
)
75.96
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Perficient Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Perficient to Showcase Salesforce Expertise at Dreamforce 2024
September 16, 2024
From
Perficient, Inc.
Via
Business Wire
Perficient Partners with Atlanta Falcons and Extends Partnership with Atlanta United
September 03, 2024
From
Perficient
Via
Business Wire
Perficient Launches its Scarlett AI Chatbot to Global Workforce
August 15, 2024
From
Perficient, Inc.
Via
Business Wire
PRFT Stock Earnings: Perficient Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
PRFT stock results show that Perficient missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Perficient Reports Second Quarter 2024 Results
August 08, 2024
From
Perficient, Inc.
Via
Business Wire
Perficient to Announce Second Quarter 2024 Results on August 8
July 26, 2024
From
Perficient, Inc.
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SOI, PRFT, ICCH, DM on Behalf of Shareholders
July 12, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
Top 5 Tech Stocks That May Crash This Quarter
July 08, 2024
Via
Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRFT, SBOW, ALIM, HCP on Behalf of Shareholders
July 02, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
PERFICIENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Perficient, Inc. - PRFT
July 02, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Perficient Named a Major Player in IDC MarketScape for Worldwide Cloud Professional Services
July 01, 2024
From
Perficient, Inc.
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBOW, PRFT, RPHM on Behalf of Shareholders
June 18, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avangrid, Inc. (NYSE - AGR), SilverBow Resources, Inc. (NYSE - SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq - RPHM), Perficient, Inc. (Nasdaq - PRFT)
June 18, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BATL, DRQ, RPHM, PRFT on Behalf of Shareholders
June 14, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avangrid, Inc. (NYSE - AGR), SilverBow Resources, Inc. (NYSE - SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq - RPHM), Perficient, Inc. (Nasdaq - PRFT)
June 07, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avangrid, Inc. (NYSE – AGR), SilverBow Resources, Inc. (NYSE – SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq – RPHM), Perficient, Inc. (Nasdaq – PRFT)
May 29, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
ALERT: Halper Sadeh LLC Continues to Investigate PRFT, SBOW, RPHM, UNIT; Shareholders are Encouraged to Contact the Firm
May 29, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avangrid, Inc. (NYSE - AGR), SilverBow Resources, Inc. (NYSE - SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq - RPHM), Perficient, Inc. (Nasdaq - PRFT)
May 20, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reneo Pharmaceuticals, Inc. (Nasdaq – RPHM), ALLETE, Inc. (NYSE – ALE), Perficient, Inc. (Nasdaq – PRFT), Hibbett, Inc. (Nasdaq – HIBB)
May 13, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
EQT Strikes A Deal For Post-Covid Tech Hangover
May 11, 2024
Dealmakers might be emerging from their bleary post-pandemic technology hangover. If Perficient’s $3 billion sale to buyout shop EQT is any indication, it could be time to pick up the pieces.
Via
Talk Markets
PERFICIENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Perficient, Inc. - PRFT
May 07, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Why Perficient Stock Raced 52% Higher Today
May 06, 2024
The company is changing hands in a multibillion-dollar deal.
Via
The Motley Fool
Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge
May 06, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Gains 1%; TreeHouse Foods Shares Fall After Q1 Results
May 06, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
May 06, 2024
Via
Benzinga
12 Information Technology Stocks Moving In Monday's Intraday Session
May 06, 2024
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ALLETE, Inc. (NYSE - ALE), Perficient, Inc. (Nasdaq - PRFT), AGBA Group Holding Limited (Nasdaq – AGBA), Hibbett, Inc. (Nasdaq – HIBB)
May 06, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
PRFT Stock Earnings: Perficient Meets EPS, Misses Revenue for Q1 2024
May 06, 2024
PRFT stock results show that Perficient met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Why Is Acutus Medical (AFIB) Stock Down 41% Today?
May 06, 2024
Acutus Medical stock is down on Monday after the company reported a delisting notice that will hit AFIB shares later this week.
Via
InvestorPlace
Why Is GlycoMimetics (GLYC) Stock Down 77% Today?
May 06, 2024
GlycoMimetics stock is falling on Monday with heavy trading of GLYC after posting lackluster results from a Phase 3 trial of uproleselan.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.